(Q43001326)

12 November 2017

title

The HCV National Register: towards informing the natural history of hepatitis C infection in the UK. (English)

1 reference

12 November 2017

H E Harris

1

1 reference

12 November 2017

M E Ramsay

2

1 reference

12 November 2017

J Heptonstall

3

1 reference

12 November 2017

K Soldan

4

1 reference

12 November 2017

K P Eldridge

5

1 reference

12 November 2017

HCV National Register Steering Group

6

1 reference

12 November 2017

publication date

1 November 2000

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

7

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

420-427

1 reference

Clinical outcomes after transfusion-associated hepatitis C.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

Hepatitis C lookback programme: a single hospital experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

Long-term persistence of hepatitis C virus antibodies in a single source outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

45-year follow-up of hepatitis C virus infection in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00255.X

10.1046/J.1365-2893.2000.00255.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference